Brief: Pyxis Oncology Announces FDA Clearance Of Two Ind Applications

Pyxis Oncology

01/12/2022 11:49

Dec 1 (Reuters) - Pyxis Oncology Inc  PYXS.O :
    * PYXIS ONCOLOGY ANNOUNCES FDA CLEARANCE OF TWO IND
APPLICATIONS
    * PYXIS ONCOLOGY INC - CASH RUNWAY EXTENDED INTO FIRST HALF
2025
    * PYXIS ONCOLOGY INC - FDA GRANTS IND CLEARANCES OF PYX-201,
AND
PYX-106, ANIMMUNOTHERAPY PRODUCT CANDIDATE
    * PYXIS ONCOLOGY INC - FDA GRANTS IND CLEARANCES OF PYX-2016
AND
PYX-106
    * PYXIS ONCOLOGY INC - LOOK FORWARD TO BEGINNING BOTH
CLINICAL
TRIALS IN EARLY 2023

Source text for Eikon:  ID:nGNX8y22lt 
Further company coverage:  PYXS.O 
 ((Reuters.Briefs@thomsonreuters.com;))